Роль семейного врача в ведении пациентов с тревожно-депрессивными расстройствами: ОБЗОРЫ

Лариса Васильевна  Щеглова; Марина Владимировна  Авдеева; Варвара Валерьевна  Попова; Ильхам Рафик оглы  Тагиев

doi:10.56871/

The role of the family doctor in the care of patients with anxiety-depressive disorders

REVIEWS

Larisa V. Shcheglova Saint Petersburg State Pediatric Medical University https://orcid.org/0000-0002-1059-4610
Marina V. Avdeeva Saint Petersburg State Pediatric Medical University; North-Western State Medical University named after I.I. Mechnikov https://orcid.org/0000-0002-4334-5434
Varvara V. Popova Saint Petersburg State Pediatric Medical University https://orcid.org/0000-0001-6524-1575
Ilham R. Tagiev Saint Petersburg State Pediatric Medical University https://orcid.org/0009-0008-8414-5472

Keywords:

family medicine general practitioner anxiety disorders depression anxiety-depressive disorders primary health care psycho-emotional health семейная медицина врач общей практики тревожные расстройства депрессия тревожно-депрессивные расстройства первичная медико-санитарная помощь психоэмоциональное здоровье

Abstract

Introduction.Urbanization with an accelerating pace of life, tension in the professional sphere, the need for daily travel at least in the “home–work–home” mode, which often requires a significant amount of time, lack of rest in general and sleep in particular, the growing information boom, significant crowding of people at home, in transport and, often, in the workplace are expected sources of stress. At the same time, additional sources of stress have emerged, such as the COVID-19 pandemic and its consequences, the tense socio-economic situation in the world, etc. All these factors negatively affect human mental health, cause excessive psycho-emotional stress and, in some cases, lead to the formation of various psychopathological conditions.The purpose of the study.To assess the effectiveness of modern approaches to the management of patients with anxiety and depressive disorders in outpatient settings in order to improve the quality of medical care and clinical outcomes, based on a systematic analysis of current literature.Materials and methods.An analysis of regulatory documents and a review of domestic and foreign publications on the management of patients with anxiety-depressive disorders in primary health care were conducted.Results and discussion.The analysis of literature and clinical cases confirmed the high prevalence of anxiety and depressive disorders and the difficulties of timely diagnosis in outpatient settings due to their masking by somatic symptoms and the stigma associated with psychiatric diagnoses. The most common manifestations of anxiety and depression are described, including both psychological and somatic complaints affecting various body systems. The use of a stepwise screening algorithm with validated scales (PHQ-9, GAD-7, HADS, etc.) and modern digital tools (e.g., the “Neuroscanner” app) is justified. The importance of a comprehensive approach involving pharmacotherapy, psychotherapy, and patient education is emphasized to improve treatment adherence and clinical outcomes.Conclusion.The family physician plays a key role in the early detection and management of patients with anxiety and depressive disorders, particularly at the level of primary health care. The use of stepwise screening and modern diagnostic tools helps improve the quality of care and prevent the chronification of psychoemotional disorders.

Author Biographies

Larisa V. Shcheglova, Saint Petersburg State Pediatric Medical University

Dr. Sci. (Med.), Professor,Head of the Family Medicine Department

Marina V. Avdeeva, Saint Petersburg State Pediatric Medical University; North-Western State Medical University named after I.I. Mechnikov

Dr. Sci.(Med.), Professor of the Family Medicine Department of the Saint
Petersburg State Pediatric Medical University; Professor of the Department of Public Health, Economics and Health Management of the North-Western State Medical University after I.I. Mechnikov

Varvara V. Popova, Saint Petersburg State Pediatric Medical University

Cand. Sci.(Med.), Associate Professor of the Family Medicine Department

Ilham R. Tagiev, Saint Petersburg State Pediatric Medical University

Resident of the 2nd year of the Family Medicine Department

References

1. Котова О.В., Беляев А.А., Акарачкова Е.С. Современные методы диагностики и лечения тревожных и депрессивных расстройств. РМЖ. Медицинское обозрение. 2021;5(10):648–653. https://doi.org/10.32364/2587-6821-2021-5-10-648-653. EDN: CQIXKM.

2. Мардиев О. Влияние тревожно-депрессивных расстройств на качество жизни больных сахарным диабетом 2-го типа. Journal of Science-Innovative Research in Uzbekistan. 2024;2(7):188–199. https://doi.org/10.5281/zenodo.12755765.

3. Santomauro D.F., Herrera A.M.M., Shadid J. et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712. https://doi.org/10.1016/S0140-6736(21)02143-7.

4. Javaid S.F., Hashim I.J., Hashim M.J. et al. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Current Psychiatry. 2023; 30(1):44. https://doi.org/10.1186/s43045-023-00315-3.

5. Оганов Р.Г., Ольбинская Л.И., Смулевич А.Б. и др. Депрессия и расстройства депрессивного спектра в общемедицинской практике. Результаты программы КОМПАС. Кардиология. 2004;44(1):48–55. EDN: OJKJTX.

6. Калинин В.В., Дамулин И.В., Земляная А.А., Ахапкин Р.В. Скрининг расстройств тревожно-депрессивного спектра: клинические и методологические аспекты. Социальная и клиническая психиатрия. 2025;35(1):62–75. EDN: JMPECS.

7. Корабельникова Е.А. Тревожные расстройства в условиях пандемии COVID-19. Медицинский вестник Северного Кавказа. 2021;16(1):79–85. https://doi.org/10. 14300/mnnc.2021.16022.

8. Tee M.L., Tee C.A., Anlacan J.P. et al. Psychological impact of COVID-19 pandemic in the Philippines. J Affect Disord. 2020;277:379–391. https://doi.org/10.1016/j.jad.2020.08.043.

9. Alkhamees A.A., Alrashed S.A., Alzunaydi A.A., Almohimeed A.S., Aljohani M.S. The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia. Compr Psychiatry. 2020;102:152192. https://doi.org/ 10.1016/j.comppsych.2020.152192.

10. Khan A.H., Sultana M.S., Hossain S. et al. The impact of COVID-19 pandemic on mental health & wellbeing among home-quarantined Bangladeshi students: A cross-sectional pilot study. J Affect Disord. 2020;277:121–128. https://doi.org/10.1016/j.jad.2020.07.135.

11. Пизова Н.В., Пизов А.В. Депрессия и посттравматическое стрессовое расстройство при новой коронавирусной инфекции. Лечебное дело. 2020;1:82–88. https://doi.org/10.24411/2071-5315-2020-12197.

12. Bäuerle A., Teufel M., Musche V. et al. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf). 2020;42(4):672–678. https://doi.org/10.1093/pubmed/fdaa106.

13. Fountoulakis K.N., Apostolidou M.K., Atsiova M.B. et al. Self-reported changes in anxiety, depression and suicidality during the COVID-19 lockdown in Greece. J Affect Disord. 2021;279:624–629. https://doi.org/10.1016/j.jad.2020.10.061.

14. Иванов Д.О., Александрович Ю.С., Горьковая И.А. Взаимосвязь смысложизненных ориентаций и тревоги у студентов медиков в первую волну пандемии. Children’s Medicine of the North-West. 2021;9(1):130–131.

15. Spytska L. Anxiety and depressive personality disorders in the modern world. Acta Psychol (Amst). 2024;246:104285. https://doi.org/10.1016/j.actpsy.2024.104285.

16. Новикова А.В., Широков В.А., Егорова А.М. Напряженность труда как фактор риска развития синдрома эмоционального выгорания и тревожно-депрессивных расстройств в различных профессиональных группах (обзор литературы). Здоровье населения и среда обитания. 2022;30(10):67–74. https://doi.org/10.35627/2219-5238/2022-30-10-67-74.

17. Qin L.I., Lan Liu, Yi Zhao et al. The Prevalance of Depression and Anxiety among Elderly People in Dai Rural Areas of Jinggu County Yunnan Province and Its Relationship with Socio-economic Status. Journal of Kunming Medical University. 2024;45(1):41–47. https://doi.org/10.12259/j.issn.2095-610X.S20240107.

18. Абдуразакова Р.Ш. Коморбидность тревожно-депрессивных расстройств с психосоматическими заболеваниями у взрослых. Central Asian Journal of Education and Innovation. 2024;3(7):22–29. https://doi.org/10.5281/zenodo.12758960.

19. Кирпиченко А.А., Барышев А.Н. Тревожные и депрессивные расстройства в общей врачебной практике: актуальные вопросы и нерешенные проблемы. Медицинский журнал. 2021;1:12–20. EDN: QPANEP.

20. Никифоров И.А., Костюк Г.П., Бурыгина Л.А. и др. Тревожные и депрессивные расстройства у населения при чрезвычайных ситуациях. М.; 2022.

21. Аронов П.В., Бельская Г.Н., Никифоров И.А. Клинический опыт ведения пациентов с тревожным расстройством. Русский медицинский журнал. 2023;3:35–38. EDN: XNNMHW.

22. Кузьмина С.В. Тревожные и связанные со стрессом расстройства в практике врача непсихиатрической специальности. Здравоохранение Чувашии. 2024;4:27–40. EDN: VECHXL.

23. Клинические рекомендации. Генерализованное тревожное расстройство. Российское общество психиатров. 2024:1–121.

24. Сюняков Т.С. Анксиолитики. Психиатрия и психофармакотерапия. 2021;23(4):9–20. EDN: KBFFKN.

25. Олейникова Т.А. Ассортиментный анализ анксиолитиков на региональном и федеральном рынках. Региональный Вестник. 2020;6(45):84–85. EDN: WYRPZV.

26. Микиртумов Б.Е. Клиническая психиатрия раннего детского возраста. СПб.: Питер; 2001.

The role of the family doctor in the care of patients with anxiety-depressive disorders: REVIEWS. (2026). Medicine: Theory and Practice, 10(4), 44-54. https://doi.org/10.56871/

Download Citation

How to Cite